Shareholder Wei Xuening of Changchun Bcht Biotechnology Co., Ltd. (688276.SH) has reduced his holding by a total of 301,800 shares in the company.

15:43 15/01/2025

Baike Biological (688276.SH) issued a statement on January 15, 2025, stating that the company has received a letter from shareholder Wei Xueling...

Changchun Bcht Biotechnology (688276.SH) announced that on January 15, 2025, the company received a notice from shareholder Mr. Wei Xuening regarding the implementation results of the reduction plan. The reduction results are as follows: Mr. Wei Xuening reduced his holdings in the company by a total of 301,800 shares through centralized bidding trading, accounting for 0.0730% of the total share capital of the company. As of the disclosure date of this announcement, the time period for this reduction plan has been completed.

Netflix (NFLX.US) has promised to maintain movie theater releases while exploring the acquisition of Warner Bros. Discovery Company's (WBD.US) streaming business.

HK Stock Market Move | HENLIUS (02696) is now up more than 4%, POHERDY has been approved for listing in the United States, covering all indications of original research products.

HK Stock Market Move | MAOYAN ENT (01896) falls more than 2%, reports claim that the ticket refund rate for the movie "Demon Slayer" has greatly increased.

Netflix (NFLX.US) has promised to maintain movie theater releases while exploring the acquisition of Warner Bros. Discovery Company's (WBD.US) streaming business.

HK Stock Market Move | HENLIUS (02696) is now up more than 4%, POHERDY has been approved for listing in the United States, covering all indications of original research products.

HK Stock Market Move | MAOYAN ENT (01896) falls more than 2%, reports claim that the ticket refund rate for the movie "Demon Slayer" has greatly increased.